#separation systems

Robustly growing Biosimilars market supported by the strong focus on reducing drug prices and cost of healthcare is poised to drive the global market for Commercial Biotechnology Separation Systems to exceed US$31.7 billion by 2024.  

Biological products are of significant importance in a wide range of sectors including food, cosmetic and pharmaceutical industries. Separating biomolecules and proteins such as RNA and DNA are key processes in commercial production of biotechnology products. These macromolecules are separated from their source material for their use in analysis as well as in production of biotechnological products. While in some applications biological products need little further processing and can be employed as crude extracts, their use in biopharmaceuticals require high levels of purity that make downstream processing with separation and purification steps critical. Separation technology is vital since it plays a major role in influencing product efficacy and ability to achieve regulatory conformance.

Separation processes in the area of biotechnology make use of a wide range of advanced separating systems including liquid chromatography, microarrays, electrophoresis, membrane filtration, flow cytometry and centrifugation technologies, among others. These biotechnology separation systems are used for a wide range of purposes, including production of enzymes, vaccines, insulin and hormones for therapeutic applications in the pharmaceutical industry, along with other uses in applications such as energy and food production. Increasing demand for biotechnology products and technological advances in separation technologies are driving growth in the market. The emergence of the pharmaceutical sector as a high impact end-use sector is fundamentally changing the way these separation devices are built, given the high safety and hygienic requirements in the pharma industry. Liquid chromatography represents the most commonly adopted separation methodology in the area of bioprocessing. From a research-dedicated tool in life sciences, liquid chromatography has evolved to become a key technology in commercial applications of biotechnology.

As stated by the new market research report on Commercial Biotechnology Separation Systems, the United States represents the largest market worldwide. Strong government support of the biosimilars market and effervescent drug pipeline in the biopharmaceutical industry, represent key factors fuelling the country’s dominance. Asia-Pacific ranks as the fastest growing market with a CAGR of 6.2% over the analysis period, led by robust lifesciences and biotechnology research activity, increased understanding of contemporary biotechnology principles and practices, and growing domestic production of drugs, food products and cosmetics.

Key players in the market include 3M, AB Sciex, Agilent Technologies Inc., Alfa Laval AB, Alfa Wassermann Separation Technologies LLC, Beckman Coulter Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Flottweg SE, Fluidigm Corporation, GE Healthcare, Groupe Novasep, Hitachi High-Technologies Corp., Illumina Inc., Merck KGaA, Pall Corporation, PerkinElmer Inc., ProMetic Life Sciences Inc., Repligen Corporation, Sartorius Stedim Biotech SA, SEPMAG, Shimadzu Scientific Instruments, Sysmex Partec GmbH, and Thermo Fisher Scientific Inc., among others.

The research report titled “Commercial Biotechnology Separation Systems - Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities of major companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East & Africa, and Latin America (Brazil, and Rest of Latin America). The types of separation system analyzed for the global market in the report include DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray, and Others.

For enquiries e-mail us at [email protected] or [email protected].